Old Web
English
Sign In
Acemap
>
authorDetail
>
Yogita Kanan
Yogita Kanan
Johns Hopkins University School of Medicine
Macular degeneration
Choroidal neovascularization
Biology
Ophthalmology
Retinal
6
Papers
74
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Suppression of Murine Choroidal and Retinal Neovascularization by Risuteganib and the Accompanying Transcriptome Changes in the OIR Retina
2021
Investigative Ophthalmology & Visual Science
Zixuan Shao
Sean F. Hackett
Raquel Formica
Yogita Kanan
Dan Zhou
John Y Park
Hampar L. Karageozian
Vicken H. Karageozian
Peter A. Campochiaro
Julia A. Kornfield
Show All
Source
Cite
Save
Citations (0)
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
2020
Nature Communications
Hiroki Tsujinaka
Jie Fu
Jikui Shen
Yun Yu
Zibran Hafiz
Joshua Kays
David McKenzie
Delia Cardona
David Culp
Ward M. Peterson
Brian C. Gilger
Christopher S. Crean
Jin Zhong Zhang
Yogita Kanan
Weiling Yu
Jeffrey L. Cleland
Ming Yang
Justin Hanes
Peter A. Campochiaro
Show All
Source
Cite
Save
Citations (19)
Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization
2020
Microvascular Research
Tomoko Ikeuchi
Yogita Kanan
Da Long
Susana de Vega
Kentaro Hozumi
Motoyoshi Nomizu
Peter A. Campochiaro
Yoshihiko Yamada
Show All
Source
Cite
Save
Citations (2)
Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage
2017
Science Translational Medicine
Raquel Lima e Silva
Yogita Kanan
Adam C. Mirando
Jayoung Kim
Ron B. Shmueli
Valeria E. Lorenc
Seth D. Fortmann
Jason Sciamanna
Niranjan B. Pandey
Jordan J. Green
Aleksander S. Popel
Peter A. Campochiaro
Show All
Source
Cite
Save
Citations (32)
1